Pembrolizumab Plus Olaparib in LA-HNSCC
Pembrolizumab Plus Olaparib in LA-HNSCC
Active, not recruiting · NCT05366166 · Registry updated 2026-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab Plus Olaparib in LA-HNSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Active, not recruiting | Phase 2 | 2026-01-28 | NCT05366166 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| UNC Lineberger Comprehensive Cancer Center | 125 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Indiana University Simon Comprehensive Cancer Center | Indianapolis | United States | 5 |
| Medical University of South Carolina (MUSC) | Charleston | United States | 34 |
| UNC Lineberger | Chapel Hill | United States | 1 |
| University of Louisville, Brown Cancer Center | Louisville | United States | 2 |